PARTIAL FATTY ACID OXIDATION (P-FOX) INHIBITORS AND COMBINED THERAPY OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

QR Code

PARTIAL FATTY ACID OXIDATION (P-FOX) INHIBITORS AND COMBINED THERAPY OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

.

Saved in:

Bibliographic Details
Main Authors:	M. E. Statsenko, S. V. Turkina, S. N. Tolstov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2011-04-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1156
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The metabolism of fatty acids and insulin secretion in children with type 1 diabetes mellitus and its complications
by: N. P. Mikaelyan, et al.
Published: (2021-06-01)

DIABETES MELLITUS AND CARDIOVASCULAR COMPLICATIONS: FOCUS ON HEMOSTASIS
by: G. G. Petrik, et al.
Published: (2014-03-01)

MEXICOR IN THE COMBINATION THERAPY OF CHRONIC HEART FAILURE AND TYPE 2 DIABETES MELLITUS
by: M. E. Statsenko, et al.
Published: (2011-12-01)

PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN DIABETES MELLITUS: THE ROLE OF ASPIRIN
by: L. A. Strizhakov
Published: (2012-04-01)

Fatty Acid Supply in Pregnant Women with Type 1 Diabetes Mellitus
by: Szabó, Éva, et al.
Published: (2011)

MILDRONATE THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE, TYPE 2 DIABETES MELLITUS AND AUTONOMOUS CARDIAC NEUROPATHY
by: M. E. Statsenko, et al.
Published: (2009-06-01)

EFFECTS OF MILDRONATE, AS A PART OF COMBINED HEART FAILURE THERAPY, ON CARBOHYDRATE AND LIPID METABOLISM AND OXIDATIVE STRESS PARAMETERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
by: M. E. Statsenko, et al.
Published: (2010-04-01)

The Influence of Non-Alc oholic Fatty Liver Disease on Indicators of Arterial Stiffness and Risk of Cardiovascular Complications in Patients with Arterial Hypertension
by: M. E. Statsenko, et al.
Published: (2020-07-01)

NEW POTENTIAL OF PHARMACEUTICAL CORRECTION OF CARDIAC AUTONOMIC NEUROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC HEART FAILURE
by: M. E. Statsenko, et al.
Published: (2011-10-01)

NONALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR COMPLICATIONS -WHAT IS THE RELATIONSHIP?
by: V. A. Azizov, et al.
Published: (2013-03-01)

Type 1 Diabetes Mellitus: Redefining the Future of Cardiovascular Complications with Novel Treatments
by: Bikhazi, Anwar B., et al.
Published: (2011)

The individual contribution of fatty acids to the development of cardiovascular diseases
by: V. S. Shramko, et al.
Published: (2025-07-01)

DIETARY FATTY ACIDS. EFFECTS ON THE RISK OF CARDIOVASCULAR DISEASES
by: N. V. Perova, et al.
Published: (2016-01-01)

EXPRESSION OF FoxP3 TRANSCRIPTION FACTOR IN BRONCHIAL ASTHMA
by: A. V. Eremeeva, et al.
Published: (2016-08-01)

Ursodeoxycholic acid preparations in the complex treatment of non-alcoholic fatty liver disease and diabetes mellitus
by: U. A. Khalilova, et al.
Published: (2023-06-01)

Hatter fox /
by: Harris, Marilyn
Published: (1973)

Prince of foxes /
by: Shellabarger, Samuel
Published: (1947)

EFFECTS OF OMEGA-3 POLYUNSATURATED FATTY ACIDS ON THE CIRCADIAN RHYTHM OF HEART RATE VARIABILITY PARAMETERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CARDIOVASCULAR AUTONOMIC NEUROPATHY
by: V. A. Serhiyenko, et al.
Published: (2018-06-01)

FATTY ACID COMPOSITION OF SERUM LIPIDS IN PATIENTS WITH DECOMPENSATED TYPE 1 DIABETES MELLITUS DEPENDING ON THE DIABETIC KETOACIDOSIS SEVERITY
by: N. V. Mukha, et al.
Published: (2019-05-01)

Diabetic Gastroenteropathy: A Complication of Diabetes Mellitus
by: Alvin Hartanto Kurniawan, et al.
Published: (2019-11-01)

Diabetic Gastroenteropathy: A Complication of Diabetes Mellitus
by: Alvin Hartanto Kurniawan, et al.
Published: (2019-11-01)

REDUCTION OF CARDIOVASCULAR COMPLICATIONS OF MODERN HYPOGLYCEMIC THERAPY OF DIABETES MELLITUS TYPE 2: "FLORENTINE HERESY"
by: A. A. Aleksandrov
Published: (2016-01-01)

HYPERTENSION AND DIABETES MELLITUS TYPE 2
by: M. E. Statsenko, et al.
Published: (2018-05-01)

Éloge to Robert Fox
by: Efthymios Nicolaidis
Published: (2017-12-01)

Role of omega-3 polyunsaturated fatty acids in cardiovascular risk management
by: V. I. Podzolkov, et al.
Published: (2020-07-01)

ω3-polyunsarturated fatty acid medications in cardiovascular event prevention
by: K. A. Talitsky, et al.
Published: (2006-12-01)

Current views on the role of fatty acids in the diagnosis of cardiovascular diseases (review)
by: O. V. Astafyeva, et al.
Published: (2021-08-01)

OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES
by: A. V. Govorin, et al.
Published: (2015-12-01)

Fatty acids /
Published: (1988)

Fatty acids
Published: (1979)

Mitochondrial Fatty Acid Beta-Oxidation Disorders in Children: Literature Review
by: Natalia V. Zhurkova, et al.
Published: (2023-01-01)

Study of the spectrum of unsaturated fatty acids in the blood of men with diabetes mellitus in Novosibirsk (ESSE-RF3 in the Novosibirsk region)
by: V. S. Shramko, et al.
Published: (2025-04-01)

COMPLICATIONS AND OUTCOMES OF PREGNANCY IN GESTATIONAL DIABETES MELLITUS
by: I. A. Bondar, et al.
Published: (2014-04-01)

Antiarrhythmic and Hemodynamic Effects of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Diseases
by: A. N. Zakirova, et al.
Published: (2022-05-01)

Non-Alcoholic Fatty Liver Disease (NAFLD), Adipocytokines and Diabetes Mellitus
by: Sheriff, Dhastagir Sultan
Published: (2011)

FATTY ACID COMPOSITION OF LIPIDS OF BACTERIA OF THE GENUS PSEUDOMONAS, OXIDIZING PETROLEUM PRODUCTS
by: Т. В. Гудзенко, et al.
Published: (2014-09-01)

Nutrient requirements of mink and foxes /
by: United States. National Research Council. Agricultural Board. Committee on Animal Nutrition. Subcommittee on Furbearer Nutrition
Published: (1968)

Comparative study of oxidative stress in diabetes mellitus
by: Baghdad Science Journal
Published: (2013-03-01)

Quality of ambulatory prevention and treatment of cardiovascular disease and its complications among Туре 2 diabetes mellitus patients
by: R. G. Oganov, et al.
Published: (2008-12-01)

Levels of Glucose-6-phosphate Dehydrogenase in Type 1 Diabetes Mellitus patients with Nephropathy and Cardiovascular disease complication
by: Baghdad Science Journal
Published: (2014-06-01)